Japanese Takeda Buys Abbott’s Stake In TAP Joint U.S. Venture
This article was originally published in PharmAsia News
Executive Summary
Japanese drug maker Takeda will establish Takeda America Holdings after finalizing a deal March 19 to obtain a 100 percent stake in TAP Pharmaceutical Products, its 50/50 joint venture with Abbott